chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Anxiety, Chills, Dizziness, Dyspnoea, Nausea
Clinical narrative: VOMITING; SHORTNESS OF BREATH; CHILLS; NAUSEA; ANXIETY; DIZZINESS; This spontaneous report received from a patient concerned a 49 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced anxiety.  On 13-APR-2021, the subject experienced dizziness. On 13-APR-2021, the subject experienced shortness of breath. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced nausea. On 17-APR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from anxiety, and shortness of breath, and had not recovered from dizziness, nausea, vomiting, and chills. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: VOMITING; SHORTNESS OF BREATH; CHILLS; NAUSEA; ANXIETY; DIZZINESS; This spontaneous report received from a patient concerned a 49 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced anxiety.  On 13-APR-2021, the subject experienced dizziness. On 13-APR-2021, the subject experienced shortness of breath. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced nausea. On 17-APR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from anxiety, and shortness of breath, and had not recovered from dizziness, nausea, vomiting, and chills. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pyrexia
Clinical narrative: FEELS AWFUL; CHILLS; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced feels awful. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feels awful, chills, and fever. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: LIGHT/REDDISH/ITCHY RASH OVER MOST OF BODY; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced light/reddish/itchy rash over most of body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of light/reddish/itchy rash over most of body was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, Taste disorder
Clinical narrative: TASTE DISTURBANCE; SMELL DISTURBANCE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203a21a,expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced taste disturbance. On 08-APR-2021, the subject experienced smell disturbance. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from taste disturbance, and smell disturbance on 08-APR-2021. This report was non-serious.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Body temperature, Confusional state, Dyspnoea, Headache
Clinical narrative: INFLAMED JOINTS; SEVERE BODY PAIN; DIFFICULTY BREATHING; MENTAL CONFUSION; HEADACHE; MUSCLE PAIN; FEVER; SORE ARM; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included depression, bipolar disorder, post traumatic stress disorder, and anxiety disorder, and other pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced sore arm. On 13-APR-2021, the subject experienced severe body pain. On 13-APR-2021, the subject experienced difficulty breathing. On 13-APR-2021, the subject experienced mental confusion. On 13-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced muscle pain. On 13-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102.3 F. On 17-APR-2021, the subject experienced inflamed joints. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 16-APR-2021, was recovering from difficulty breathing, had not recovered from severe body pain, muscle pain, headache, and mental confusion, and the outcome of sore arm and inflamed joints was not reported. This report was non-serious.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: INFLAMED JOINTS; SEVERE BODY PAIN; DIFFICULTY BREATHING; MENTAL CONFUSION; HEADACHE; MUSCLE PAIN; FEVER; SORE ARM; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included depression, bipolar disorder, post traumatic stress disorder, and anxiety disorder, and other pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced sore arm. On 13-APR-2021, the subject experienced severe body pain. On 13-APR-2021, the subject experienced difficulty breathing. On 13-APR-2021, the subject experienced mental confusion. On 13-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced muscle pain. On 13-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102.3 F. On 17-APR-2021, the subject experienced inflamed joints. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 16-APR-2021, was recovering from difficulty breathing, had not recovered from severe body pain, muscle pain, headache, and mental confusion, and the outcome of sore arm and inflamed joints was not reported. This report was non-serious.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Fatigue, Influenza
Clinical narrative: FLU SYMPTOMS; CHILLS "SHE WAS COLD"; DIARRHEA; VOMITING; LOSS OF APPETITE; FATIGUE; NAUSEA; This spontaneous report received from a consumer. The patient's concurrent conditions included lupus, non smoker, abstain from alcohol, and allergy, and other pre-existing medical conditions included no illicit drug usage. The patient was previously treated with ergocalciferol, meloxicam, alprazolam, pantoprazole, gabapentin, hydroxychloroquine sulfate, rosuvastatin, and acetylsalicylic acid.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 14-APR-2021, the subject experienced loss of appetite. On 14-APR-2021, the subject experienced fatigue. On 14-APR-2021, the subject experienced nausea. On 15-APR-2021, the subject experienced diarrhea. On 15-APR-2021, the subject experienced vomiting. On 15-APR-2021, the subject experienced chills "she was cold". On an unspecified date, the subject experienced flu symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the diarrhea, vomiting, nausea, fatigue, chills "she was cold", loss of appetite and flu symptoms was not reported. This report was non-serious.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: FLU SYMPTOMS; CHILLS "SHE WAS COLD"; DIARRHEA; VOMITING; LOSS OF APPETITE; FATIGUE; NAUSEA; This spontaneous report received from a consumer. The patient's concurrent conditions included lupus, non smoker, abstain from alcohol, and allergy, and other pre-existing medical conditions included no illicit drug usage. The patient was previously treated with ergocalciferol, meloxicam, alprazolam, pantoprazole, gabapentin, hydroxychloroquine sulfate, rosuvastatin, and acetylsalicylic acid.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 14-APR-2021, the subject experienced loss of appetite. On 14-APR-2021, the subject experienced fatigue. On 14-APR-2021, the subject experienced nausea. On 15-APR-2021, the subject experienced diarrhea. On 15-APR-2021, the subject experienced vomiting. On 15-APR-2021, the subject experienced chills "she was cold". On an unspecified date, the subject experienced flu symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the diarrhea, vomiting, nausea, fatigue, chills "she was cold", loss of appetite and flu symptoms was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Lymphadenopathy
Clinical narrative: SUPRACLAVICULAR LYMPHADENOPATHY; SHORTNESS OF BREATH; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 05-APR-2021, the subject experienced shortness of breath. On an unspecified date, the subject experienced grasping for air sensation, and supraclavicular lymphadenopathy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shortness of breath, and grasping for air sensation, and the outcome of supraclavicular lymphadenopathy was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Influenza, Nasopharyngitis
Clinical narrative: COLD SYMPTOMS; FLU SYMPTOMS; SICKNESS FOR 48 HRS; This spontaneous report received from contact via a company representative concerned a male patient of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination.   The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced cold symptoms. On APR-2021, the subject experienced flu symptoms. On APR-2021, the subject experienced sickness for 48 hrs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cold symptoms, flu symptoms, and sickness for 48 hrs. This report was non-serious.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Influenza like illness, Lip swelling
Clinical narrative: SWEATY; SWOLLEN LIP; CHILLS; TIRED; FEVERISH; ITCHY FOREARMS; FLU-LIKE SYMPTOMS; ACHEY; This spontaneous report received from a patient concerned a 56 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced itchy forearms. On APR-2021, the subject experienced flu-like symptoms. On APR-2021, the subject experienced achey. On APR-2021, the subject experienced tired. On APR-2021, the subject experienced feverish. On an unspecified date, the subject experienced sweaty, swollen lip, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the flu-like symptoms, tired, achey, feverish, sweaty, chills, swollen lip and itchy forearms was not reported. This report was non-serious.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pruritus, Pyrexia
Clinical narrative: SWEATY; SWOLLEN LIP; CHILLS; TIRED; FEVERISH; ITCHY FOREARMS; FLU-LIKE SYMPTOMS; ACHEY; This spontaneous report received from a patient concerned a 56 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced itchy forearms. On APR-2021, the subject experienced flu-like symptoms. On APR-2021, the subject experienced achey. On APR-2021, the subject experienced tired. On APR-2021, the subject experienced feverish. On an unspecified date, the subject experienced sweaty, swollen lip, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the flu-like symptoms, tired, achey, feverish, sweaty, chills, swollen lip and itchy forearms was not reported. This report was non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule
Clinical narrative: RED, HARD, PAINFUL BUMP AT  INJECTION SITE; This spontaneous report received from a consumer concerned a 48 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included lupus, peanuts / all nuts allergy, and apple/pears allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced red, hard, painful bump at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red, hard, painful bump at injection site. This report was non-serious.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: HEADACHE; FEVER; This spontaneous report received from a patient concerned a 23 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043a21a, expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on APR-2021, and had not recovered from headache. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: FEVER; HANGOVER-LIKE HEADACHES; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 2021, the subject experienced fever. On 2021, the subject experienced hangover-like headaches. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and hangover-like headaches on 2021. This report was non-serious.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain in extremity
Clinical narrative: LEG PAIN AND CALLER COULD NOT BEND DOWN ALL THE WAY AND HAVING A HARD TIME GOING UP AND DOWN THE STAIRS; FATIGUE; FLU LIKE SYMPTOMS ON 16TH MARCH AND IT WAS WORSENED ON 9TH APRIL TO 11TH APRIL; This spontaneous report received from a patient concerned a 66 year old female. The patient's weight was 97 pounds, and height was 66 inches. The patient's concurrent conditions included bell's palsy on right side of face;, nonsmoker, and abstains from alcohol, and other pre-existing medical conditions included no unknown allergies no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. Concomitant medications included clonazepam for muscle relaxant for bell's palsy.  On 16-MAR-2021, the subject experienced flu like symptoms on 16th march and it was worsened on 9th april to 11th april. On 04-APR-2021, the subject experienced leg pain and caller could not bend down all the way and having a hard time going up and down the stairs. On 04-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 16th march and it was worsened on 9th april to 11th april on 12-APR-2021, and had not recovered from leg pain and caller could not bend down all the way and having a hard time going up and down the stairs, and fatigue. This report was non-serious.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue
Clinical narrative: SHORTNESS OF BREATH; FATIGUE; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies and normally had to take anti-histamines in the spring. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. Concomitant medications included levocetirizine. On 13-APR-2021, the subject experienced shortness of breath. On 13-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shortness of breath, and fatigue. This report was non-serious.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Burning sensation, COVID-19, Chills, Pain
Clinical narrative: ITCHING; SWELLING ON FACE; BURNING SENSATION; HIVES; RASH; BUMP; FEVER; BODY ACHES; CHILLS; This spontaneous report received from a patient concerned a 23 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included asthma, and alcohol user. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 17:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On NOV-2020, Laboratory data included: COVID-19 (NR: not provided) Positive. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 101.4 F, 98.8 F. On 09-APR-2021 02:00, the subject experienced body aches. On 09-APR-2021 02:00, the subject experienced chills. On 09-APR-2021 02:00, the subject experienced fever. On 15-APR-2021, the subject experienced itching. On 15-APR-2021, the subject experienced swelling on face. On 15-APR-2021, the subject experienced burning sensation. On 15-APR-2021, the subject experienced hives. On 15-APR-2021, the subject experienced rash. On 15-APR-2021, the subject experienced bump. Treatment medications included: cortisone, and diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, and fever on 10-APR-2021, and itching on 16-APR-2021, was recovering from hives, rash, swelling on face, and bump, and had not recovered from burning sensation. This report was non-serious.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Rash, Rash pruritic, Swelling face
Clinical narrative: ITCHING; SWELLING ON FACE; BURNING SENSATION; HIVES; RASH; BUMP; FEVER; BODY ACHES; CHILLS; This spontaneous report received from a patient concerned a 23 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included asthma, and alcohol user. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 17:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On NOV-2020, Laboratory data included: COVID-19 (NR: not provided) Positive. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 101.4 F, 98.8 F. On 09-APR-2021 02:00, the subject experienced body aches. On 09-APR-2021 02:00, the subject experienced chills. On 09-APR-2021 02:00, the subject experienced fever. On 15-APR-2021, the subject experienced itching. On 15-APR-2021, the subject experienced swelling on face. On 15-APR-2021, the subject experienced burning sensation. On 15-APR-2021, the subject experienced hives. On 15-APR-2021, the subject experienced rash. On 15-APR-2021, the subject experienced bump. Treatment medications included: cortisone, and diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, and fever on 10-APR-2021, and itching on 16-APR-2021, was recovering from hives, rash, swelling on face, and bump, and had not recovered from burning sensation. This report was non-serious.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: ITCHING; SWELLING ON FACE; BURNING SENSATION; HIVES; RASH; BUMP; FEVER; BODY ACHES; CHILLS; This spontaneous report received from a patient concerned a 23 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included asthma, and alcohol user. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 17:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On NOV-2020, Laboratory data included: COVID-19 (NR: not provided) Positive. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 101.4 F, 98.8 F. On 09-APR-2021 02:00, the subject experienced body aches. On 09-APR-2021 02:00, the subject experienced chills. On 09-APR-2021 02:00, the subject experienced fever. On 15-APR-2021, the subject experienced itching. On 15-APR-2021, the subject experienced swelling on face. On 15-APR-2021, the subject experienced burning sensation. On 15-APR-2021, the subject experienced hives. On 15-APR-2021, the subject experienced rash. On 15-APR-2021, the subject experienced bump. Treatment medications included: cortisone, and diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, and fever on 10-APR-2021, and itching on 16-APR-2021, was recovering from hives, rash, swelling on face, and bump, and had not recovered from burning sensation. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: CHILLS; SLIGHT FEVER; HEADACHE; EXHAUSTION; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.  No concomitant medications were reported. On an unspecified date, the subject experienced chills, slight fever, headache, and exhaustion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, slight fever, headache, and exhaustion. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea
Clinical narrative: SICK AFTER TAKING VACCINE; NAUSEA; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced sick after taking vaccine, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sick after taking vaccine, and nausea. This report was non-serious. This case, from the same reporter is linked to 20210436706 and 20210436253.
Sex: U
Vaccine: COVID19
Symptoms: Bronchospasm, Chest X-ray, Chills, SARS-CoV-2 test
Clinical narrative: CHILLS; BRONCHOSPASM; This spontaneous report received from a patient concerned an 80 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included slight cough. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: 23-JUN-2021) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced bronchospasm. Laboratory data included: Chest X-ray (NR: not provided) Clear lungs. On 10-APR-2021, the subject experienced chills. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and the outcome of bronchospasm was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity, Tachycardia
Clinical narrative: TACHYCARDIA; PAIN IN ARM; HEADACHE; NAUSEA; This spontaneous report received from a patient via a company representative concerned a 41 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. . The batch number was not provided and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced tachycardia, pain in arm, headache, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tachycardia, headache, nausea and pain in arm was not reported. This report was non-serious.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache
Clinical narrative: SHORTNESS OF BREATH; HEADACHE; This spontaneous report received from a patient concerned a 54 year old male. The patient's weight, height, and medical history were not reported.   The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 18-APR-2021, the subject experienced shortness of breath. On 18-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shortness of breath, and headache. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Fatigue, Headache, Nausea
Clinical narrative: HEADACHE/HEAD HURTING; FELT NAUSEA; FELT FATIGUE/TIRED; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included low blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid.  On 08-APR-2021, the subject experienced headache/head hurting. On 08-APR-2021, the subject experienced felt nausea. On 08-APR-2021, the subject experienced felt fatigue/tired.  Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) 120/62 mmHg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache/head hurting, felt nausea, and felt fatigue/tired. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: BODY ACHES; FEVER; EXHAUSTION; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, fever, and exhaustion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, fever, and exhaustion. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: LOST SENSE OF TASTE; LOST SENSE OF SMELL; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced lost sense of taste. On APR-2021, the subject experienced lost sense of smell. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lost sense of taste and lost sense of smell was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: LIGHT HEADEDNESS; BRAIN FOG; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the subject experienced light headedness, and brain fog. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the light headedness and brain fog was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Pallor, Polymenorrhoea
Clinical narrative: EARLY MENSTRUAL CYCLE; PALLOR; LIGHT HEADED; WEAKNESS; This spontaneous report received from a health care professional concerned a 54 year old female. The patient's weight was 150 pounds, and height was 64 inches. The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not have known drug allergies and drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced early menstrual cycle. On 13-APR-2021, the subject experienced pallor. On 13-APR-2021, the subject experienced light headed. On 13-APR-2021, the subject experienced weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from early menstrual cycle, had not recovered from pallor, and weakness, and the outcome of light headed was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: PAIN IN ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced pain in arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pain in arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20210430209.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Chills, Cough, Diarrhoea
Clinical narrative: DIARRHEA; STOMACH PAIN; BACK PAIN; COUGH; SHORTNESS OF BREATH; RUNNY NOSE; CHILLS; FEELING TIRED/ FATIGUE; FEVER; This spontaneous report received from a patient concerned an 86 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included ulcers, blood count are always high, allergies to pain medication, and cigarette smoker, and other pre-existing medical conditions included patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 206A21A expiry: 23-JUN-2023) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced fever. On 13-APR-2021, the subject experienced back pain. On 13-APR-2021, the subject experienced cough. On 13-APR-2021, the subject experienced shortness of breath. On 13-APR-2021, the subject experienced runny nose. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced feeling tired/ fatigue. On 15-APR-2021, the subject experienced diarrhea. On 15-APR-2021, the subject experienced stomach pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 15-APR-2021, was recovering from feeling tired/ fatigue, diarrhea, stomach pain, back pain, cough, shortness of breath, and runny nose, and the outcome of fever was not reported. This report was non-serious.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Pyrexia, Rhinorrhoea
Clinical narrative: DIARRHEA; STOMACH PAIN; BACK PAIN; COUGH; SHORTNESS OF BREATH; RUNNY NOSE; CHILLS; FEELING TIRED/ FATIGUE; FEVER; This spontaneous report received from a patient concerned an 86 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included ulcers, blood count are always high, allergies to pain medication, and cigarette smoker, and other pre-existing medical conditions included patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 206A21A expiry: 23-JUN-2023) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced fever. On 13-APR-2021, the subject experienced back pain. On 13-APR-2021, the subject experienced cough. On 13-APR-2021, the subject experienced shortness of breath. On 13-APR-2021, the subject experienced runny nose. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced feeling tired/ fatigue. On 15-APR-2021, the subject experienced diarrhea. On 15-APR-2021, the subject experienced stomach pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 15-APR-2021, was recovering from feeling tired/ fatigue, diarrhea, stomach pain, back pain, cough, shortness of breath, and runny nose, and the outcome of fever was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Headache, Malaise, Nausea, Photophobia
Clinical narrative: LIGHT SENSITIVITY; HAVENT FELT GOOD; STOMACH PAINS AND CRAMPS; VOMITING; SEVERE HEADACHE; NAUSEA; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. Batch number was not reported. As Per procedure no follow up will be required for this case. No concomitant medications were reported.  On APR-2021, the subject experienced light sensitivity. On APR-2021, the subject experienced havent felt good. On APR-2021, the subject experienced stomach pains and cramps. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced severe headache. On APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the severe headache, stomach pains and cramps, nausea, vomiting, light sensitivity and havent felt good was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: LIGHT SENSITIVITY; HAVENT FELT GOOD; STOMACH PAINS AND CRAMPS; VOMITING; SEVERE HEADACHE; NAUSEA; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. Batch number was not reported. As Per procedure no follow up will be required for this case. No concomitant medications were reported.  On APR-2021, the subject experienced light sensitivity. On APR-2021, the subject experienced havent felt good. On APR-2021, the subject experienced stomach pains and cramps. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced severe headache. On APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the severe headache, stomach pains and cramps, nausea, vomiting, light sensitivity and havent felt good was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hypersomnia, Pain, Pyrexia
Clinical narrative: ACHY; SLEEPING ALL DAY; COLD CHILLS; TIRED; SLIGHT FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced achy, sleeping all day, cold chills, tired, and slight fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achy, sleeping all day, cold chills, tired, and slight fever. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Nausea, Oropharyngeal pain, Throat irritation
Clinical narrative: SORE THROAT; FATIGUED; NAUSEA; WENT TO BED 5HRS EARLY; RAW THROAT; FEELING UNEASY; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be  requested for this case. No concomitant medications were reported.  On 13-APR-2021, the subject experienced raw throat. On 13-APR-2021, the subject experienced feeling uneasy. On 13-APR-2021, the subject experienced nausea. On 13-APR-2021, the subject experienced went to bed 5hrs early. On 14-APR-2021, the subject experienced sore throat. On 14-APR-2021, the subject experienced fatigued. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the raw throat, nausea, feeling uneasy, sore throat, fatigued and went to bed 5hrs early was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: UNKNOWN SIDE EFFECTS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced unknown side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unknown side effects was not reported. This report was non-serious.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia
Clinical narrative: PAIN IN ARM WHERE THE VACCINE HAD /NAGGING TO SHARP PAIN ALL DAY; ENTIRE BICEP IS SORE; This spontaneous report received from a patient concerned a 52 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and good health. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 14:30 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.  No concomitant medications were reported. On 11-APR-2021, the subject experienced pain in arm where the vaccine had /nagging to sharp pain all day. On 11-APR-2021, the subject experienced entire bicep is sore. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in arm where the vaccine had /nagging to sharp pain all day, and entire bicep is sore. This report was non-serious.